andarine

Other names: (2S)-3-(4-acetamidophenoxy)-2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide, SARM S-4, S-4 cpd, S4, propanamide, 3-(4-(acetylamino)phenoxy)-2-hydroxy-2-methyl-N-(4-nitro-3-(trifluoromethyl)phenyl)-, (2S)-, 3-(4-acetylaminophenoxy)-2-hydroxy-2-methyl-N-(4-nitro-3-trifluoromethylphenyl)-propionamide, S-4, S-3-(4-acetylaminophenoxy)-2-hydroxy-2-methyl-N-(4-nitro-3-trifluoromethylpheanyl)propionamide, GTX-007, androxolutamide, GTx 007, 3-(4-acetylamino-phenoxy)-2-hydroxy-2-methyl-N-(4-nitro-3-trifluoromethylphenyl)propionamide, acetamidoxolutamide, tetrathietane

Classifications: 6000

Reasons for prohibition: - WADA S1: Anabolic Agents (source) - Unapproved Drug - FDA Statement

References: - {'title': 'NIH NCATS Inxight Drugs entry: Andarine', 'url': 'https://drugs.ncats.io/drug/7UT2HAH49H'} - {'title': 'FDA warns against using SARMs in body-building products', 'url': 'https://www.fda.gov/news-events/fda-brief/fda-brief-fda-warns-against-using-sarms-body-building-products'}

Reason: WADA S1: Anabolic Agents; Unapproved drug; FDA statement: SARMs

Label terms: []

Searchable name: andarine

GUID: 532d1956-a8aa-4481-bbfd-06e3a8a6b292

Added: 2026-01-01T00:09:47.312568+00:00

Updated: {"_seconds": 1738871209, "_nanoseconds": 825000000}